Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;49(4):402-405.
doi: 10.1007/s12029-018-0169-1.

Faecal Occult Blood Point-of-Care Tests

Affiliations
Review

Faecal Occult Blood Point-of-Care Tests

Barbara Kościelniak-Merak et al. J Gastrointest Cancer. 2018 Dec.

Abstract

Background: Early detection of colorectal cancer decreases the risk of mortality. Faecal occult blood tests (FOBT) are recognised as a useful tool for colorectal cancer screening. These non-invasive, rapid, and easy-to-carry assays are very often used as a point-of-care test and for self-testing. On the market, there are various types of FOB tests available, including chemical and immunochromatographic tests, which are based on different detection methods and differ in their sensitivity and specificity.

Conclusions: Clinicians should be aware of the causes of false-negative and false-positive test results, which can vary depending on the test. Additionally, stool sampling bias may be a source of error and must be considered by the clinician. The current FOBT methods are subject to various interfering factors; items such as proper preparation of the patient prior to testing or the clinician's knowledge of testing limitations are key in correct interpreting results. Novel technologies such as FOBT DNA tests, micro RNA tests, and biochips equipped with bacteria can indicate bleeding from the gastrointestinal tract and improve diagnostics process.

Keywords: Colorectal cancer; Immunochemistry; Occult blood; Point-of-care; Screening; Stool sampling.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

    1. Craven O. Screening for colorectal cancer using the fecal occult blood test: a critical literature review. Eur J Oncol Nurs. 2001;5:234–243. doi: 10.1054/ejon.2001.0137. - DOI - PubMed
    1. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med. 1997;126:811–822. doi: 10.7326/0003-4819-126-10-199705150-00014. - DOI - PubMed
    1. Villeneuve PJ, Coombs A. Screening for colorectal cancer using the fecal occult blood test: an actuarial assessment of the impact of a population-based screening program in Canada. Int J Technol Assess Health Care. 2003;19:715–723. doi: 10.1017/S0266462303000692. - DOI - PubMed
    1. American Cancer Society. Cancer facts & figures 2018. Atlanta, GA: American Cancer Society; 2018.
    1. https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-st.... Accessed 22 May 2018.

MeSH terms

LinkOut - more resources